Scilife

Scilife

Software Development

Antwerp, Flemish Region 47,897 followers

The Smart Quality Platform

About us

Because when we all embrace quality, brilliant things happen! At Scilife, we help people and companies transform quality into a catalyst for value creation, making Smart Quality a culture and infusing it throughout the entire organization. This recasts quality as a competitive advantage instead of a simple regulatory requirement. But, what embeds quality into a company’s culture? And how, exactly, does an organization benefit as a result? These questions are at the core of Scilife. The Scilife Smart Quality Platform brings clarity to quality and compliance by combining powerful quality management tools with advanced data analytics, augmented learning, and gamification. Hundreds of leading life sciences companies worldwide like Novartis, Biocartis, Yusen Logistics, Polpharma, Pendulum, and many more trust Scilife to manage their quality processes, empower employees to take quality ownership, enhance efficiency and transparency, and reduce compliance risk. The impact? Improving patients’ lives. With Scilife, organizations reduced their total cost of quality assurance by up to 50% and accelerated their time to market by as much as 30%. Ready for the bright future of Smart Quality? ➡️ http://scilife.io Our fast-growing team is scattered around the world and works 100% remotely, from Jodhpur to Antwerp, and from Barcelona to Miami. We’re an eclectic bunch with wide-ranging skills united by intellectual curiosity and a passion for creating truly innovative solutions. Does that sound like you? How about the people you see yourself working with? ➡️ http://scilife.io/career

Website
http://scilife.io
Industry
Software Development
Company size
51-200 employees
Headquarters
Antwerp, Flemish Region
Type
Self-Owned
Specialties
Quality by Design, Quality management, QMS, Workflow automation, FDA 21 CFR part 11, CAPAs, Document control, Change control, Quality Assurance, Risk Assessment, Validation, Audit, Regulatory affairs and compliance, Life-changing breakthroughs, Life Sciences, Digital transformation, CRO laboratories, Good Laboratory Practices, GAMP 5, and ATMP

Products

Locations

Employees at Scilife

Updates

  • View organization page for Scilife, graphic

    47,897 followers

    Are compliance and innovation friends or foes? 🤔 Both are crucial: #innovation propels the industry forward, while #compliance is the foundation that holds everything together, ensures patient safety, and builds trust. That’s why striking a balance can feel like walking on a tightrope. Compliance is about following rules to ensure patient safety, but the implementation of rules can be tricky. Innovation can help when industries are not prepared to comply with changing regulations. The truth is that regulations are not ready-made solutions; they often force companies to think creatively and work together when they are rolled out. This is where innovative solutions can meet regulations. The trick is to adhere to regulations, innovate, and validate the innovation. Focus on small opportunities, one step at a time, to create a culture of innovation in compliance. By viewing regulations as a framework rather than a barrier, your company can foster cutting-edge innovation that is also safe, ethical, and compliant. Therefore, innovation and compliance are not foes, they are complementary forces that drive the industry forward. Compliance ensures innovation can flourish safely and ethically. Here are some more ideas:  ✅  Integrate compliance from the start: Involve regulatory teams from the beginning of drug or solution development. ✅  Embrace technology: Utilize data analytics, AI, and other emerging technologies to enhance compliance by providing real-time monitoring and risk assessment. This will fast-track drug development while ensuring safety. ✅  Regular training: Ensure all staff, especially R&D, are regularly updated on compliance requirements. ✅  Collaborative approach: View regulators as partners, working together to understand regulations and find innovative ways to meet them. By embracing a proactive, collaborative, and transparent approach to compliance, pharma tech companies can build trust and unlock innovative potential within the boundaries of regulation - creating therapies that are safe, ethical, and compliant. How do you strike the balance between innovation and compliance? 

    • No alternative text description for this image
  • View organization page for Scilife, graphic

    47,897 followers

    #AI is promising safer drugs - are you embracing its potential? In the dynamic world of pharmaceuticals, prioritizing #PatientSafety remains crucial. With the emergence of new drugs and expanded treatment options, the significance of #pharmacovigilance, which involves monitoring and assessing drug safety, has never been more apparent. The industry is embracing the revolutionary potential of artificial intelligence (AI) and cutting-edge technology to address the increasing complexity of pharmacovigilance tasks and enhance drug safety surveillance. Traditional pharmacovigilance methods encounter challenges such as manual data collection, limited scalability, and delayed reporting, which can result in potential risks going unnoticed. The integration of AI in pharmacovigilance is poised to introduce a new era of proactive, data-driven safety monitoring by providing unprecedented insights into #DrugSafety signals and patterns and enabling earlier detection of potential adverse events and improved risk management strategies. This transformation represents a pivotal moment in the evolution of pharmacovigilance, leading to faster identification of safety issues and ultimately safer drugs for patients. It opens the door to a future where patient safety is safeguarded with unprecedented precision and efficiency, unlocking new frontiers in drug safety. Read this blog to learn about the challenges and opportunities of AI in pharma: https://lnkd.in/defFsUQn 

  • View organization page for Scilife, graphic

    47,897 followers

    In the world of #QualityAssurance, there are many satisfying moments, each one reminding us why we love what we do. But, what truly stands out among these beautiful experiences? We want to hear from you! What comes close to the exquisite feeling of zero findings in audits? 😍  People following your SOPs: Witnessing your team not deviating from the SOP and actually adhering to the standards you've meticulously set is a truly satisfying moment.  🤑  Receiving more budget for QA: It’s not easy for top management to approve a budget for QA until disaster strikes and a warning letter comes in. So, when it happens, many of us shout victory.  🤩  Non-QAs caring about quality: Many misunderstand the role of quality and it’s certainly not easy to change mindsets. But when you do, it feels like you’ve achieved the impossible. Vote now and let us know which of these moments brings you the greatest satisfaction in your QA journey! OR perhaps you have more you’d like to share! 

    This content isn’t available here

    Access this content and more in the LinkedIn app

  • View organization page for Scilife, graphic

    47,897 followers

    Curious about how AI can enhance the detection and mitigation of compliance risks? Wondering how to effectively train your team to leverage AI tools? 🎙 Join Neeru Bakshi, Chief Quality Officer, and Àngel Buendía, Knowledge Manager, as they delve into these critical questions and more in an exclusive interview on the future of regulatory compliance in the AI era. Inside, you'll find: ✅ Expert insights on integrating AI into your compliance strategy ✅ Practical advice for training your team to work with AI tools ✅ A comprehensive infographic detailing how to ensure AI compliance and tackle common challenges And more! Don’t miss out—read the full interview now and stay ahead in the evolving landscape of AI and regulatory compliance!

    Coffee chat with Scilife’s QA: How AI will impact regulatory compliance and how to take action

    Coffee chat with Scilife’s QA: How AI will impact regulatory compliance and how to take action

    Scilife on LinkedIn

  • View organization page for Scilife, graphic

    47,897 followers

    Hey curious learner - that could be your name on our Quality Management Systems certification! Just as trees thrive with the right care and environment, you too can flourish by mastering essential skills in deviation management, CAPA, change management, and risk assessment. This course equips you with the tools to identify and resolve quality issues, implement corrective actions, and manage risks effectively. With practical insights from industry standards like ISO 9001 and ICH Q9, you'll cultivate a strong foundation for continuous improvement. 📚 There are four courses included in this certification - complete them all to receive your certificate! Course 1: Introduction to Deviation Management and root-cause analysis Course 2: Introduction to CAPA Course 3: Introduction to Change Management Course 4: Introduction to Quality Risk Management Join us and watch your professional growth soar as you learn to ensure quality and compliance in life sciences! 🌳✨ Access all our certifications here: https://lnkd.in/dpKgRcgZ #ScilifeAcademy #ContinuousLearning

    • No alternative text description for this image
  • View organization page for Scilife, graphic

    47,897 followers

    To successfully import your #medicaldevices into the U.S. market after obtaining 510(k) clearance, you must navigate a series of regulated steps. This process is essential for ensuring compliance with U.S. laws and regulations, ultimately safeguarding public health and safety. For a detailed guide on these steps, check out our latest blog: https://lnkd.in/dGWmtUWP Steps to import medical devices in the US: 1️⃣ Determine Device Classification: Identify the device's classification (Class I, II, or III) based on its risk level and understand the specific requirements for each class. 2️⃣ Establishment Registration and Device Listing: Both the importer and the foreign manufacturer must register their establishments with the FDA and ensure that each device intended for import is listed. 3️⃣ Premarket Requirements: For Class II devices, submit a premarket notification (510(k)) to demonstrate substantial equivalence to a legally marketed device. 4️⃣ Appoint a U.S. Agent: Foreign manufacturers must appoint a U.S. agent to facilitate communication with the FDA. 5️⃣ Comply with Quality System Regulation (QSR): Ensure compliance with the FDA’s Quality System Regulation, including adherence to good manufacturing practices. 6️⃣ Labeling Compliance: Verify that device labeling meets FDA regulations, providing necessary information for safe and effective use. 7️⃣ Prepare Import Documentation: Gather all required documentation, including FDA registration numbers, device listing details, and 510(k) or PMA numbers if applicable. 8️⃣ Customs Entry Process: Submit entry documentation to U.S. Customs and Border Protection (CBP) for clearance and be prepared to provide additional information if requested. 9️⃣ FDA and CBP Inspection: Shipments may be inspected upon arrival to verify compliance with regulatory requirements; issues may lead to detention until compliance is confirmed. 🔟 Adverse Event Reporting and Post-Market Surveillance: Comply with Medical Device Reporting (MDR) regulations by reporting adverse events or device malfunctions to the FDA and implementing post-market surveillance to monitor device performance and safety. By following these steps, you can effectively navigate the importation process for your medical devices in the U.S. market, ensuring that your hard work in obtaining 510(k) clearance leads to successful commercialization.

  • View organization page for Scilife, graphic

    47,897 followers

    Smart Quality Summit 2024 is your golden ticket to future-proofing your QMS and conquering the toughest regulatory hurdles. How, you ask? We've assembled the crème de la crème of industry experts to share their invaluable insights! Buckle up as we unveil our first groundbreaking session:  DigitalHealth, AI and Software—lean regulatory market access now and in future Our first talk will cover: - Regulatory Frameworks: Learn about the current regulations impacting digital health, including the FDA, EU MDR/IVDR, IMDRF, and the EU AI Act. - Future Trends: Discuss emerging regulatory trends and enforcement challenges that are shaping the landscape of healthcare. - Market Access Strategies: Discover effective strategies for lean regulatory market access, such as creating a single technical file and collaborating with contract legal manufacturers. - Case Studies: Gain insights from real-world examples that illustrate successful regulatory market access strategies, equipping you with key takeaways to streamline processes and foster innovation. 🗣 Meet our expert: Rudolf Wagner With 15+ years of experience, Rudolf is a Quality and Regulatory powerhouse. He's led global teams to rapid certifications and successfully registered medical devices in 132 countries. His cross-industry expertise in Pharma, Medical Devices, and Digital Health makes him the perfect guide for your regulatory journey. 🎓 Earn a valuable certificate for attending! 🗓️ 14 NOV | Virtual Event Don't let regulatory challenges hold you back. Register now and propel your QMS into the future: https://lnkd.in/edsRK68f #SmartQualitySummit2024 #LifeSciences #Pharma #MedicalDevice #QA

    • No alternative text description for this image
  • View organization page for Scilife, graphic

    47,897 followers

    The life sciences industry generates an astonishing 10 terabytes of data daily—equivalent to 5 billion pages of text. Yes, you’ve read that right. What’s more #data is growing exponentially which can present significant challenges for companies in managing and storing this data. To navigate this data deluge, #lifescience organizations must develop a comprehensive data management strategy that clearly defines roles, responsibilities, and best practices. Key to this strategy is the allocation of a data steward, who ensures data compliance, security, and adherence to the #FAIRprinciples—making data findable, accessible, interoperable, and reusable. Embracing technologies like blockchain, #AI, cloud computing, and IoT can revolutionize data management in life sciences. AI and machine learning can analyze vast datasets to identify patterns and predict trends, enhancing supply chain transparency and drug safety. Meanwhile, IoT can improve patient-centered care and regulatory compliance. By leveraging these technologies, life science companies can overcome #datamanagement challenges, driving innovation, optimizing supply chains, and ultimately improving patient access to vital treatments. Read our blog to overcome the biggest data management challenges: https://lnkd.in/dF4cwies

  • View organization page for Scilife, graphic

    47,897 followers

    Contrary to the naming, the Internet of Medical Things or #IoMT is not the Internet. Instead, it's a network of devices connected to each other. But before we dive into IoMT, do you know what is #IoT? The Internet of Things (IoT) is a network of different devices with sensors, software, and cloud connections, allowing these "smart devices" to connect and communicate. The devices of IoT are typically sensors and actuators. Sensors collect information about the surrounding environment, while actuators make changes to the environment. An IoT system also requires cloud connectivity and analytical tools to process the data and provide commands. 🌐 IoT vs. IoMT: What is the difference?  While IoT has a broad scope, applicable to various industries, the IoMT is specifically focused on the healthcare domain. IoMT establishes a system that connects "people-to-people, people-to-things, and things-to-things" within a healthcare setting. The IoMT system starts with #MedicalDevices, such as imaging machines, wearables, and electronic health records, that collect health data. This data is then sent to a central server or cloud for analysis, where it can be presented to healthcare professionals, trigger alerts, and recognize patterns to support better decision-making and patient care. IoMT enables the digitalization of patient data records and treatment, improving the accuracy of diagnosis and allowing for a multidisciplinary approach to care. It also facilitates large-scale data collection and analysis, which can be valuable during outbreaks or for research purposes. Additionally, IoMT systems can provide real-time monitoring and alerts for patients with severe or chronic conditions, improving their quality of life and enabling them to live more independently. Curious to learn more about IoMT? Read our glossary ➡ https://lnkd.in/dN8jQSYA

Affiliated pages

Similar pages

Funding

Scilife 1 total round

Last Round

Series unknown
See more info on crunchbase